Notably, in addition to inhibiting lipid synthesis, research has revealed an increase in lipophagy, which can be attributed at least partly to the alleviation of fatty liver symptoms by liver-specific CRTC2 KO. This evidence concerns the gene CRTC2 and Hepatic steatosis.